Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071513 · ClinicalTrials.gov registry record · Phase 1
Middle School to High School Transition Project: Depression and Substance Abuse Prevention
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 497
- Enrollment target
NCT00071513: Completed Phase 1 study, sponsored by University of Washington.
NCT00071513 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 497 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (728% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00071513, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 497 participants
- Enrollment target
Study Summary
This study will implement a school-based program to prevent depression, academic failure, and substance use in at-risk adolescents transitioning from middle school to high school.
Primary Outcome
The Short Moods and Feelings Questionnaire is a 13 item measure of level of self reported depressive symptoms. Each item in scored on a 3-point Likert scale as follows: "True" (0), "Sometimes" (1), and "Not True" (2) rated within the timeframe of the previous two weeks. A total score is obtained; scores can range from 0 to 26. Total scores of 12 or higher may signify that a child/adolescent is suffering from depression. Higher scores on this scale suggest a worse outcome or greater endorsement o
Interventions
- BEHAVIORAL Brief Intervention
- BEHAVIORAL CAST-T/HSTS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 497 participants |
| Start Date | 2003-03 |
| Est. Completion | 2007-06 |
| Phase | Phase 1 |
What the finished NCT00071513 record still lists
NCT00071513 is an interventional study that assigns participants to a tested intervention. The registered 497 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (728% higher).
The record links to 0 conditions, and to 2 interventions - of which Brief Intervention is the first listed.
NCT00071513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00071513 about?
NCT00071513 is a clinical study titled "Middle School to High School Transition Project: Depression and Substance Abuse Prevention". This study will implement a school-based program to prevent depression, academic failure, and substance use in at-risk adolescents transitioning from middle school to high school.
What is the current status of trial NCT00071513?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 497 participants. The study started on 2003-03. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00071513?
The interventions under investigation include: Brief Intervention (BEHAVIORAL), CAST-T/HSTS (BEHAVIORAL).
Who is sponsoring clinical trial NCT00071513?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00071513's enrollment target sits among peer trials
497 47th of 2000 higher than 1,954 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03175224 · 497 participants · Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- NCT05301816 · 497 participants · NA
PDN Post Market, Multicenter, Prospective, Global Clinical Study
- NCT05766670 · 497 participants · Phase 3
Intramedullary Calcium Sulfate Antibiotic Depot
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia